Accelevation (NASDAQ:ACCV) Research Coverage Started at JPMorgan Chase & Co.

JPMorgan Chase & Co. began coverage on shares of Accelevation (NASDAQ:ACCV) in a research note issued to investors on Monday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $20.00 price target on the stock.

A number of other brokerages have also recently weighed in on ACCV. The Goldman Sachs Group started coverage on Accelevation in a research note on Monday. They issued a “buy” rating and a $22.00 price objective for the company. Wall Street Zen raised Accelevation to a “hold” rating in a research note on Saturday, October 10th. Bank of America initiated coverage on Accelevation in a research note on Monday. They set a “buy” rating and a $20.00 target price on the stock. Barclays initiated coverage on Accelevation in a report on Monday. They set an “overweight” rating and a $20.00 target price for the company. Finally, Robert W. Baird started coverage on Accelevation in a research report on Monday. They issued an “outperform” rating and a $16.00 target price for the company. Seven analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $19.43.

Accelevation Price Performance

NASDAQ:ACCV opened at $15.03 on Monday. Accelevation has a 52 week low of $11.58 and a 52 week high of $18.10.

Insider Activity at Accelevation

In other Accelevation news, CEO Michael Rubiera purchased 200,000 shares of the company’s stock in a transaction on Thursday, October 1st. The stock was acquired at an average price of $18.00 per share, for a total transaction of $3,600,000.00. Following the completion of the purchase, the chief executive officer directly owned 1,424,285 shares in the company, valued at approximately $25,637,130. The trade was a 16.34% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Howard C. Heckes purchased 5,000 shares of the company’s stock in a transaction on Thursday, October 1st. The stock was acquired at an average price of $18.00 per share, with a total value of $90,000.00. Following the purchase, the director owned 5,000 shares of the company’s stock, valued at approximately $90,000. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 227,700 shares of company stock worth $4,098,600 over the last 90 days.

Accelevation News Summary

Here are the key news stories impacting Accelevation this week:

• Positive Sentiment: Goldman Sachs began covering Accelevation with a “buy” rating and a $22.00 price target, implying significant upside from the referenced share price. Goldman Sachs coverage and recommendation
• Positive Sentiment: Barclays initiated coverage with an “overweight” rating and a $20.00 price target, also signaling confidence in ACCV’s future performance. Barclays coverage and recommendation
• Neutral Sentiment: Bank of America initiated coverage on Accelevation, adding another major institution to the company’s analyst following. The available report does not disclose a rating or price target. Bank of America initiates coverage on Accelevation
• Neutral Sentiment: JPMorgan Chase added Accelevation to its analyst coverage universe. No rating or target price was provided in the available information. JPMorgan Chase covers Accelevation
• Neutral Sentiment: Morgan Stanley, Wolfe Research, and Robert W. Baird also initiated coverage, increasing ACCV’s visibility among institutional investors. Their ratings and price targets were not disclosed in the supplied reports. Morgan Stanley initiates coverage Wolfe Research initiates coverage Robert W. Baird initiates coverage

About Accelevation

Accelevation Corporation (NASDAQ: ACCV) is a special purpose acquisition company (SPAC) formed to identify and combine with an operating business through a merger, share exchange, asset acquisition, reorganization or similar transaction.

Unlike an operating company, Accelevation does not manufacture products, provide ongoing commercial services or conduct significant business activities of its own. Its primary activities have consisted of evaluating potential acquisition targets and pursuing a business combination.

Public information about Accelevation’s operating history, geographic footprint and leadership is limited.